📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery (2019)

First Author: Poser S

Attributed to: Defining the role of FOSL2 in molecular adaptation to hypoxia in colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.201802603rr

PubMed Identifier: 31145643

Publication URI: http://europepmc.org/abstract/MED/31145643

Type: Journal Article/Review

Parent Publication: The FASEB Journal

Issue: 8

ISSN: 0892-6638